News
Category: Friederichs Ataxia
Global clinical trial contract wins in Alzheimer’s Disease and Friedreich’s Ataxia
12 August 2025 IXICO plc (AIM: IXI) – London, UK. IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug development in neurological disorders, today announced it has signed two separate new commercial contracts to provide neuroimaging services across different core therapeutic indications.